OncoMed Pharmaceuticals Inc. (NASDAQ: OMED) announced updated survival data from a Phase 1b clinical trial of tarextumab (anti-Notch2/3, OMP-59R5) for the treatment of small cell lung cancer.
OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) belongs to Healthcare sector. Its weekly performance is -2.56%. On last trading day company shares ended up at $9.50.
NGL Energy Partners LP (NYSE:NGL) announces that Robert W. (“Trey”) Karlovich III has been appointed Executive Vice President and Chief Financial Officer. Mr. Karlovich recently served as the Chief Financial Officer for Targa Pipeline Partners, LP, a subsidiary of Targa Resources Partners LP, from February 2015 through February 2016 and as Senior Vice President of Commercial and Business Development for Targa Resources Partners LP from November 2015 through February 2016. Mr. Karlovich served in various roles at Atlas Pipeline Partners, L.P. and its subsidiaries (“APL”) from September 2006 through February 2015 when APL merged with Targa Resources Partners LP, most recently as Chief Financial Officer (since November 2011) and Chief Accounting Officer (since November 2009).
NGL Energy Partners LP (NYSE:NGL) shares decreased -2.00% in last trading session and ended the day at $7.83. NGL Gross Margin is 7.50% and its return on assets is -0.30%. NGL Energy Partners LP (NYSE:NGL) quarterly performance is -52.69%.
On 17 February, Grand Canyon Education, Inc. (NASDAQ:LOPE) reported Net revenue increased 13.7% to $216.0 million for the fourth quarter of 2015, compared to $190.0 million for the fourth quarter of 2014. End-of-period enrollment increased 9.9% to 74,506 at December 31, 2015, from 67,806 at December 31, 2014, as ground enrollment increased 19.2% to 15,195 at December 31, 2015, from 12,746 at December 31, 2014 and online enrollment increased 7.7% to 59,311 at December 31, 2015, from 55,060 at December 31, 2014.
On 24 February, Grand Canyon Education, Inc. (NASDAQ:LOPE) shares increased 1.03% and was closed at $38.39. LOPE EPS growth in last 5 year was 29.60%. Grand Canyon Education, Inc. (NASDAQ:LOPE) year to date (YTD) performance is -4.31%.
Cerner (NASDAQ: CERN) reported Q4 EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.18 billion. GUIDANCE: Cerner sees Q1 2016 EPS of $0.52-$0.54, versus the consensus of $0.54. Cerner sees Q1 2016 revenue of $1.15-1.2 billion, versus the consensus of $1.18 billion. Cerner sees FY2016 EPS of $2.30-$2.40, versus the consensus of $2.36. Cerner sees FY2016 revenue of $4.9-5.1 billion, versus the consensus of $5.02 billion.
Cerner Corporation (NASDAQ:CERN) ended the last trading day at $51.79. Company weekly volatility is calculated as 3.37% and price to cash ratio as 34.31. Cerner Corporation (NASDAQ:CERN) showed a weekly performance of -1.93%.
On 18 February, Pan American Silver Corp. (NASDAQ:PAAS) reported net loss during Q4 2015 declined by $388.8 million from Q4 2014 primarily due to a decline of $412.8 million in net of tax impairment charges and a $13.6 million reduction in mine operating losses. During Q4 2015, the Company recorded $121.5 million in pre-tax impairment charges on the value of mineral properties, and plant and equipment at Morococha, Dolores and Alamo Dorado.
Pan American Silver Corp. (NASDAQ:PAAS) shares remains unchanged in last trading session and ended the day at $9.42. PAAS Gross Margin is -6.80% and its return on assets is -31.70%. Pan American Silver Corp. (NASDAQ:PAAS) quarterly performance is 41.44%.